annual CFI:
$136.49M+$247.74M(+222.70%)Summary
- As of today (September 13, 2025), BMRN annual cash flow from investing activities is $136.49 million, with the most recent change of +$247.74 million (+222.70%) on December 31, 2024.
- During the last 3 years, BMRN annual CFI has risen by +$502.80 million (+137.26%).
- BMRN annual CFI is now -48.37% below its all-time high of $264.35 million, reached on December 31, 2018.
Performance
BMRN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$12.59M+$15.65M(+55.41%)Summary
- As of today (September 13, 2025), BMRN quarterly cash flow from investing activities is -$12.59 million, with the most recent change of +$15.65 million (+55.41%) on June 30, 2025.
- Over the past year, BMRN quarterly CFI has dropped by -$103.07 million (-113.92%).
- BMRN quarterly CFI is now -102.73% below its all-time high of $461.25 million, reached on December 31, 2014.
Performance
BMRN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$19.42M-$103.07M(-84.15%)Summary
- As of today (September 13, 2025), BMRN TTM cash flow from investing activities is $19.42 million, with the most recent change of -$103.07 million (-84.15%) on June 30, 2025.
- Over the past year, BMRN TTM CFI has increased by +$53.94 million (+156.25%).
- BMRN TTM CFI is now -95.91% below its all-time high of $474.86 million, reached on September 30, 2018.
Performance
BMRN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BMRN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +222.7% | -113.9% | +156.3% |
| 3 y3 years | +137.3% | +57.6% | +116.6% |
| 5 y5 years | +539.9% | +94.9% | +111.3% |
BMRN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.3% | -113.9% | +80.6% | -85.8% | +114.1% |
| 5 y | 5-year | at high | +137.3% | -111.8% | +94.9% | -85.8% | +105.3% |
| alltime | all time | -48.4% | +111.6% | -102.7% | +98.3% | -95.9% | +101.7% |
BMRN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$12.59M(-55.4%) | $19.42M(-84.1%) |
| Mar 2025 | - | -$28.24M(-137.0%) | $122.49M(-10.3%) |
| Dec 2024 | $136.49M(-222.7%) | $76.40M(-572.9%) | $136.49M(-2899.2%) |
| Sep 2024 | - | -$16.16M(-117.9%) | -$4.88M(-85.9%) |
| Jun 2024 | - | $90.48M(-735.6%) | -$34.52M(-63.8%) |
| Mar 2024 | - | -$14.24M(-78.1%) | -$95.47M(-14.2%) |
| Dec 2023 | -$111.24M(+455.4%) | -$64.96M(+41.8%) | -$111.24M(+10.2%) |
| Sep 2023 | - | -$45.80M(-255.1%) | -$100.99M(+28.5%) |
| Jun 2023 | - | $29.53M(-198.4%) | -$78.59M(-43.0%) |
| Mar 2023 | - | -$30.01M(-45.1%) | -$137.82M(+588.1%) |
| Dec 2022 | -$20.03M(-94.5%) | -$54.71M(+133.8%) | -$20.03M(-3.4%) |
| Sep 2022 | - | -$23.40M(-21.2%) | -$20.74M(-82.3%) |
| Jun 2022 | - | -$29.70M(-133.8%) | -$117.19M(-43.6%) |
| Mar 2022 | - | $87.78M(-258.4%) | -$207.74M(-43.3%) |
| Dec 2021 | -$366.31M(+583.2%) | -$55.42M(-53.8%) | -$366.31M(+22.2%) |
| Sep 2021 | - | -$119.85M(-0.3%) | -$299.87M(+309.0%) |
| Jun 2021 | - | -$120.26M(+69.9%) | -$73.32M(-63.7%) |
| Mar 2021 | - | -$70.79M(-742.0%) | -$201.81M(+276.4%) |
| Dec 2020 | -$53.62M(+72.8%) | $11.03M(-89.7%) | -$53.62M(-52.8%) |
| Sep 2020 | - | $106.70M(-142.9%) | -$113.54M(-33.8%) |
| Jun 2020 | - | -$248.75M(-421.4%) | -$171.56M(-277.1%) |
| Mar 2020 | - | $77.40M(-258.3%) | $96.86M(-412.2%) |
| Dec 2019 | -$31.03M(-111.7%) | -$48.90M(-200.4%) | -$31.03M(-41.6%) |
| Sep 2019 | - | $48.68M(+147.5%) | -$53.09M(-117.7%) |
| Jun 2019 | - | $19.67M(-139.0%) | $300.56M(+5.2%) |
| Mar 2019 | - | -$50.48M(-28.9%) | $285.61M(+8.0%) |
| Dec 2018 | $264.35M(-186.5%) | -$70.96M(-117.6%) | $264.35M(-44.3%) |
| Sep 2018 | - | $402.33M(+8420.2%) | $474.86M(-232.8%) |
| Jun 2018 | - | $4.72M(-106.6%) | -$357.69M(-11.1%) |
| Mar 2018 | - | -$71.73M(-151.4%) | -$402.24M(+31.7%) |
| Dec 2017 | -$305.46M(-36.9%) | $139.55M(-132.4%) | -$305.46M(-59.5%) |
| Sep 2017 | - | -$430.23M(+980.4%) | -$754.65M(+15.9%) |
| Jun 2017 | - | -$39.82M(-259.0%) | -$651.36M(+21.5%) |
| Mar 2017 | - | $25.05M(-108.1%) | -$536.00M(+10.7%) |
| Dec 2016 | -$484.05M(-59.0%) | -$309.65M(-5.3%) | -$484.05M(+410.3%) |
| Sep 2016 | - | -$326.94M(-532.8%) | -$94.85M(-156.1%) |
| Jun 2016 | - | $75.54M(-1.9%) | $169.01M(-148.1%) |
| Mar 2016 | - | $77.00M(-3.2%) | -$351.73M(-70.2%) |
| Dec 2015 | -$1.18B(-706.3%) | $79.55M(-226.1%) | -$1.18B(+47.8%) |
| Sep 2015 | - | -$63.08M(-85.8%) | -$797.90M(-13.5%) |
| Jun 2015 | - | -$445.20M(-40.7%) | -$922.05M(+78.3%) |
| Mar 2015 | - | -$750.87M(-262.8%) | -$517.22M(-365.8%) |
| Dec 2014 | $194.56M(-165.1%) | $461.25M(-346.4%) | $194.56M(-133.9%) |
| Sep 2014 | - | -$187.23M(+363.8%) | -$573.11M(+49.8%) |
| Jun 2014 | - | -$40.37M(+3.3%) | -$382.57M(+16.0%) |
| Mar 2014 | - | -$39.09M(-87.2%) | -$329.94M(+10.4%) |
| Dec 2013 | -$298.78M(+52.7%) | -$306.42M(-9348.9%) | -$298.78M(+568.1%) |
| Sep 2013 | - | $3.31M(-73.0%) | -$44.72M(-35.2%) |
| Jun 2013 | - | $12.26M(-254.4%) | -$68.98M(-70.5%) |
| Mar 2013 | - | -$7.94M(-84.8%) | -$233.62M(+19.4%) |
| Dec 2012 | -$195.65M(+118.5%) | -$52.35M(+149.9%) | -$195.65M(+9.8%) |
| Sep 2012 | - | -$20.95M(-86.3%) | -$178.21M(-17.3%) |
| Jun 2012 | - | -$152.38M(-607.3%) | -$215.58M(+245.0%) |
| Mar 2012 | - | $30.04M(-186.0%) | -$62.49M(-30.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$89.56M(-11.6%) | -$34.91M(-40.1%) | -$89.56M(+31.2%) |
| Sep 2011 | - | -$58.32M(-8360.8%) | -$68.26M(+389.6%) |
| Jun 2011 | - | $706.00K(-76.2%) | -$13.94M(-49.8%) |
| Mar 2011 | - | $2.97M(-121.8%) | -$27.77M(-72.6%) |
| Dec 2010 | -$101.34M(+27.2%) | -$13.61M(+239.8%) | -$101.34M(-23.9%) |
| Sep 2010 | - | -$4.00M(-69.5%) | -$133.25M(-22.6%) |
| Jun 2010 | - | -$13.13M(-81.4%) | -$172.12M(+40.4%) |
| Mar 2010 | - | -$70.60M(+55.1%) | -$122.58M(+53.9%) |
| Dec 2009 | -$79.67M(+317.6%) | -$45.52M(+6.2%) | -$79.67M(-10.3%) |
| Sep 2009 | - | -$42.87M(-217.8%) | -$88.85M(+184.5%) |
| Jun 2009 | - | $36.40M(-231.5%) | -$31.23M(-78.9%) |
| Mar 2009 | - | -$27.69M(-49.4%) | -$148.13M(+676.5%) |
| Dec 2008 | -$19.08M(-87.4%) | -$54.70M(-470.8%) | -$19.08M(-42.6%) |
| Sep 2008 | - | $14.75M(-118.3%) | -$33.23M(-176.3%) |
| Jun 2008 | - | -$80.49M(-179.4%) | $43.56M(-155.0%) |
| Mar 2008 | - | $101.36M(-247.2%) | -$79.24M(-47.5%) |
| Dec 2007 | -$151.00M(-22.5%) | -$68.85M(-175.2%) | -$151.00M(-13.8%) |
| Sep 2007 | - | $91.54M(-145.0%) | -$175.13M(-50.2%) |
| Jun 2007 | - | -$203.29M(-786.7%) | -$351.32M(+99.6%) |
| Mar 2007 | - | $29.60M(-131.8%) | -$176.00M(-9.6%) |
| Dec 2006 | -$194.77M(-438.1%) | -$92.98M(+9.8%) | -$194.77M(+91.5%) |
| Sep 2006 | - | -$84.65M(+202.7%) | -$101.69M(+623.6%) |
| Jun 2006 | - | -$27.96M(-358.2%) | -$14.05M(-137.6%) |
| Mar 2006 | - | $10.83M(>+9900.0%) | $37.37M(-35.1%) |
| Dec 2005 | $57.60M(-476.7%) | $90.00K(-97.0%) | $57.60M(-12.0%) |
| Sep 2005 | - | $2.99M(-87.3%) | $65.42M(-19.1%) |
| Jun 2005 | - | $23.45M(-24.5%) | $80.91M(+199.0%) |
| Mar 2005 | - | $31.07M(+292.7%) | $27.06M(-277.0%) |
| Dec 2004 | -$15.29M(-70.0%) | $7.91M(-57.2%) | -$15.29M(-73.4%) |
| Sep 2004 | - | $18.48M(-160.8%) | -$57.58M(-34.2%) |
| Jun 2004 | - | -$30.40M(+169.5%) | -$87.50M(+9.9%) |
| Mar 2004 | - | -$11.28M(-67.2%) | -$79.65M(+56.3%) |
| Dec 2003 | -$50.95M(-171.9%) | -$34.38M(+200.3%) | -$50.95M(-399.2%) |
| Sep 2003 | - | -$11.45M(-49.2%) | $17.03M(-63.2%) |
| Jun 2003 | - | -$22.54M(-229.4%) | $46.31M(-37.5%) |
| Mar 2003 | - | $17.42M(-48.2%) | $74.13M(+4.5%) |
| Dec 2002 | $70.91M(-153.0%) | $33.60M(+88.5%) | $70.91M(-221.2%) |
| Sep 2002 | - | $17.83M(+237.5%) | -$58.53M(-30.3%) |
| Jun 2002 | - | $5.28M(-62.8%) | -$83.95M(-35.8%) |
| Mar 2002 | - | $14.20M(-114.8%) | -$130.81M(-2.3%) |
| Dec 2001 | -$133.91M(+8517.4%) | -$95.84M(+1163.0%) | -$133.91M(+281.4%) |
| Sep 2001 | - | -$7.59M(-81.8%) | -$35.11M(+42.6%) |
| Jun 2001 | - | -$41.59M(-474.8%) | -$24.62M(+129.0%) |
| Mar 2001 | - | $11.10M(+273.6%) | -$10.75M(+591.7%) |
| Dec 2000 | -$1.55M(-97.7%) | $2.97M(+2.3%) | -$1.55M(-85.3%) |
| Sep 2000 | - | $2.90M(-110.5%) | -$10.61M(-83.0%) |
| Jun 2000 | - | -$27.72M(-236.6%) | -$62.27M(+33.2%) |
| Mar 2000 | - | $20.29M(-433.7%) | -$46.76M(-32.0%) |
| Dec 1999 | -$68.75M(+739.3%) | -$6.08M(-87.5%) | -$68.75M(+9.7%) |
| Sep 1999 | - | -$48.76M(+299.5%) | -$62.67M(+350.7%) |
| Jun 1999 | - | -$12.20M(+617.5%) | -$13.91M(+717.5%) |
| Mar 1999 | - | -$1.70M | -$1.70M |
| Dec 1998 | -$8.19M(+679.2%) | - | - |
| Dec 1997 | -$1.05M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual CFI year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly CFI year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM CFI year-on-year change?
What is BioMarin Pharmaceutical Inc. annual cash flow from investing activities?
The current annual CFI of BMRN is $136.49M
What is the all time high annual CFI for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual cash flow from investing activities is $264.35M
What is BioMarin Pharmaceutical Inc. annual CFI year-on-year change?
Over the past year, BMRN annual cash flow from investing activities has changed by +$247.74M (+222.70%)
What is BioMarin Pharmaceutical Inc. quarterly cash flow from investing activities?
The current quarterly CFI of BMRN is -$12.59M
What is the all time high quarterly CFI for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly cash flow from investing activities is $461.25M
What is BioMarin Pharmaceutical Inc. quarterly CFI year-on-year change?
Over the past year, BMRN quarterly cash flow from investing activities has changed by -$103.07M (-113.92%)
What is BioMarin Pharmaceutical Inc. TTM cash flow from investing activities?
The current TTM CFI of BMRN is $19.42M
What is the all time high TTM CFI for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM cash flow from investing activities is $474.86M
What is BioMarin Pharmaceutical Inc. TTM CFI year-on-year change?
Over the past year, BMRN TTM cash flow from investing activities has changed by +$53.94M (+156.25%)